Cyclerion Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Employees
- 1
- Market Cap
- $6.9M
- Website
- http://www.cyclerion.com
- Introduction
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was fo...
Calluna Pharma appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as ...
Calluna Pharma appoints Mark Gaffney as CEO and Mark Altmeyer as Chair of the Board. Gaffney brings 20+ years of biotech experience, previously at Oxular and Vedere Bio. Altmeyer, with extensive pharma and biotech leadership, currently chairs AM-Pharma and serves on several boards. Calluna's lead candidate, CAL101, is on track to complete Phase 1 this year.
Calluna Pharma Names CEO
Calluna Pharma appoints Mark Gaffney as CEO; Gaffney brings 20+ years of experience in biotech, previously CEO of Oxular Limited and COO at Vedere Bio (acquired by Novartis). Gaffney will lead Calluna's strategy as CAL101 completes Phase 1 this year.
© Copyright 2024. All Rights Reserved by MedPath